Why we will beat Alcon/Novaris/Ciba and J&J

Anonymous

Guest
We are driving our sales this year with a long term strategy that is much better than our competitors. Also, with initiatives to become leaner and meaner we should be able to drive down the cost of doing business and put out competitive pricing that will leave our competition in the dust.

We could use some help from D&R but maybe with the new head of D&R he will reorganize it so that we can get some new products to sell soon.
 












We are driving our sales this year with a long term strategy that is much better than our competitors. Also, with initiatives to become leaner and meaner we should be able to drive down the cost of doing business and put out competitive pricing that will leave our competition in the dust.

We could use some help from D&R but maybe with the new head of D&R he will reorganize it so that we can get some new products to sell soon.

hey stupid......wake up! you're dreaming again.
 


















Dude...whoever wrote this deserves the swift unemployment that comes with a private equity selloff. Alcon, Novartis/Ciba, and J&J are NOT OWNED BY PRIVATE EQUITY, you r*****. Whatever company bull they want to say at B+L means jack when the company is being sold off or chopped up and sold off. They will simply state that due to a recent merger/sale with XYZ Company, the employees at B+L will no longer have a job in 2 weeks. Simple as that. Whatever vision, roadmap, R&D, jargon they want to throw around is quite simply useless.
 






The original poster here is an idiot.
Alcon is the 500lb gorilla and B&L isn't even a turd in the corner of the cage.

B&L would aspire to be anyone of the companies on that list and isn't even close.
Without Vision care, B&L is even more of a joke than it is. Every single division of B&L is 3rd rate to any company on that list, and a 3rd rate comparison is generous at best.